Last April 28th to May 1st, we had the pleasure of attending the AUA Annual Meeting 2023. This event brought together, in Chicago (USA), urologists from around the world to show the latest scientific advances in the field of Urology.
Thanks to this meeting we have been able to access more than a hundred hours of science and share experiences with other prestigious professionals.
The team of urologists from ROC Clinic and HM Hospitales presented three research papers related, on the one hand, with the surgical approach to benign prostatic hyperplasia and, on the other hand, with erectile dysfunction in obese men:
- A prospective multicenter comparison between holmium laser enucleation of the prostate (holep) and aquabeam robotic system for the treatment of benign prostatic hyperplasia: Prostatic enucleation is currently considered the gold standard surgical treatment for benign prostatic hyperplasia (BPH). Aquablation is an emerging robotic system that uses a high-energy water jet and real-time ultrasound imaging for the selective destruction of the prostatic adenoma as a surgical treatment for BPH. The aim of this study is to compare the efficacy and safety of holmium laser enucleation of the prostate (HoLEP) and ablation with the Aquabeam system for the surgical treatment of BPH.
- Initial experience with superpulsed thulium laser in prostate enucleaction: prospective randomized multicenter comparative study between HoLEP and ThuLEP in terms of efficacy and safety. La enucleación prostática con láser de holmium (HoLEP) is the reference method for the surgical treatment of Benign Prostatic Hyperplasia and its results have been widely demonstrated. The new superpulsed thulium laser (TFL) could be a good alternative to holmium in prostate enucleation. This study compares the efficacy and safety of HoLEP 100 W versus TFL 60 W in prostate enucleation (ThuLEP) in the surgical treatment of BPH.
- Abdominoplasy and PP insertion: a new standard for obese patients? Sexual dysfunction is very common in adult men with obesity. Penile prosthesis implantation has proven to be an effective option for patients who do not respond to non-surgical treatments. Its implantation, together with abdominoplasty, could be an alternative treatment in obese patients to improve satisfaction and facilitate sexual intercourse.
My sincere congratulations to the organizers of this event. Living this experience together with other colleagues has been enormously enriching.
I would also like to thank my entire team for their involvement in science and research and their constant commitment to disseminating information for the benefit of patients.
